Major histocompatibility complex class II transactivator gene polymorphism: Associations with Löfgren's syndrome

Tissue Antigens

Volumn 76, Issue 2, 2010, Pages 96-101

  Grunewald, J ^a   Idali, F ^a,b   Kockum, I ^a   Seddighzadeh, M ^a   Nisell, M ^a   Eklund, A ^a   Padyukov, L ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b AVICENNA RESEARCH INSTITUTE   (Iran)

Author keywords

genetics; L fgren's syndrome; major histocompatibility complex class II transactivator; sarcoidosis

Indexed keywords

HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; ETHNICITY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFECTION RISK; LOFGREN SYNDROME; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOIDOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENES, MHC CLASS II; HLA-DR ANTIGENS; HLA-DRB1 CHAINS; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SARCOIDOSIS; SYNDROME; TRANS-ACTIVATORS; YOUNG ADULT;

EID: 77954330568     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2010.01476.x     Document Type: Article

References (31)

1. Iannuzzi M, Rybicki B, Teirstein A. Medical progress: sarcoidosis. N Engl J Med 2007 : 357 : 2153 2165.
2. Muller-Quernheim J, Schurmann M, Hofmann S et al. Genetics of sarcoidosis. Clin Chest Med 2008 : 29 : 391 414.
3. Spagnolo P, du Bois RM. Genetics of sarcoidosis. Clin Dermatol 2007 : 25 : 242 249.
4. Grunewald J. Genetics of sarcoidosis. Curr Opin Pulm Med 2008 : 14 : 434 439.
5. Hofmann S, Franke A, Fischer A et al. Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis. Nat Genet 2008 : 40 : 1103 1106
6. Schurmann M, Lympany PA, Reichel P et al. Familial sarcoidosis is linked to the major histocompatibility complex region. Am J Respir Crit Care Med 2000 : 162 : 861 864.
7. Schurmann M, Reichel P, Muller-Myhsok B, Schlaak M, Muller-Quernheim J, Schwinger E. Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med 2001 : 164 : 840 846.
8. Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997 : 156 : 1601 1605.
9. Löfgren S. Erythema nodosum: studies on etiology and pathogenesis in 185 adult cases. Acta Med Scand 1946 : 124 : 1 197.
10. Hedfors E, Lindstrom F. HLA-B8/DR3 in sarcoidosis. Correlation to acute onset disease with arthritis. Tissue Antigens 1983 : 22 : 200 203.
11. Gardner J, Kennedy HG, Hamblin A, Jones E. HLA associations in sarcoidosis: a study of two ethnic groups. Thorax 1984 : 39 : 19 22.
12. Martinetti M, Tinelli C, Kolek V et al. 'The sarcoidosis map': a joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med 1995 : 152 : 557 564.
13. Bogunia-Kubik K, Tomeczko J, Suchnicki K, Lange A. HLA-DRB1*03, DRB1*11 or DRB1*12 and their respective DRB3 specificities in clinical variants of sarcoidosis. Tissue Antigens 2001 : 57 : 87 90.
14. Sato H, Grutters JC, Pantelidis P et al. HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am J Respir Cell Mol Biol 2002 : 27 : 406 412.
15. Grunewald J, Eklund A, Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med 2004 : 169 : 696 702.
16. Grunewald J, Eklund A. Lofgren's syndrome: human leukocyte antigen strongly influences the disease course. Am J Respir Crit Care Med 2009 : 179 : 307 312.
17. Spagnolo P, Sato H, Grunewald J et al. A common haplotype of the C-C chemokine receptor 2 gene and HLA-DRB1*0301 are independent genetic risk factors for Lofgren's syndrome. J Intern Med 2008 : 264 : 433 441.
18. Friese M, Jones Y, Fugger L. MHC II molecules in inflammatory diseases: interplay of qualities and quantities. Trends Immunol 2005 : 26 : 559 561.
19. Swanberg M, Lidman O, Padyukov L et al. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 2005 : 37 : 486 494.
20. Martinez A, Sanchez-Lopez M, Varade J et al. Role of the MHC2TA gene in autoimmune diseases. Ann Rheum Dis 2007 : 66 : 325 329.
21. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999 : 160 : 736 755.
22. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993 : 41 : 119 134.
23. Voorter CE, Amicosante M, Berretta F, Groeneveld L, Drent M, van den Berg-Loonen EM. HLA class II amino acid epitopes as susceptibility markers of sarcoidosis. Tissue Antigens 2007 : 70 : 18 27.
24. O'Doherty C, Hawkins S, Rooney M, Vandenbroeck K. The MHC2TA-168A/G and +1614G/C polymorphisms and risk for multiple sclerosis or chronic inflammatory arthropathies. Tissue Antigens 2007 : 70 : 247 251.
25. Eyre S, Bowes J, Spreckley K et al. Investigation of the MHC2TA gene, associated with rheumatoid arthritis in a Swedish population, in a UK rheumatoid arthritis cohort. Arthritis Rheum 2006 : 54 : 3417 3422.
26. Bronson PG, Criswell LA, Barcellos LF. The MHC2TA-168A/G polymorphism and risk for rheumatoid arthritis: a meta-analysis of 6861 patients and 9270 controls reveals no evidence for association. Ann Rheum Dis 2008 : 67 : 933 936.
27. Moller DR, Chen ES. Genetic basis of remitting sarcoidosis: triumph of the trimolecular complex? Am J Respir Cell Mol Biol 2002 : 27 : 391 395.
28. Iannuzzi MC. Genetics of sarcoidosis. Semin Respir Crit Care Med 2007 : 28 : 15 21.
29. Idali F, Wiken M, Wahlstrom J et al. Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosis. Eur Respir J 2006 : 27 : 451 459.
30. Wahlstrom J, Dengjel J, Persson B et al. Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis. J Clin Invest 2007 : 117 : 3576 3582.
31. Candore G, Modica MA, Lio D et al. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: a genetically determined defect of C4 influences immunological parameters of healthy carriers of the haplotype. Biomed Pharmacother 2003 : 57 : 274 277.